Gene Detection Market Size, Trends, Insights, Report 2023-2030

Description
Segmentation & Scope

Rise in Cancer Testing to Drive Gene Detection Market Growth

Use of gene detection in cancer testing is likely to spearhead in the coming years. Various gene detection methods are available to diagnose mutations and variants in DNA sequence that could result in excessive growth of cells consequently increasing the possibility of tumor growth. For example, various methods such as CHEK2 (for colorectal and breast cancer), RAD51D and BRIP1 (for ovarian cancer) and PALB2 (for pancreatic cancer) are available. In addition, rising cancer cases worldwide have prompted individuals to carry out preventive diagnosis and adopt personalized medicine. In turn, rising awareness among people is expected to drive demand for gene detection services. According to Global Cancer Observatory, cancer incidences worldwide were 19,292,789 in 2020 of which 9,958,133 deaths were observed. As per IARC (International Agency for Research on Cancer) analysis, new cancer incidences are likely to touch 30 million by end of 2040. With efficient gene detection, it will become possible to get information on cancer possibility in household and risk of development of new cancers in the coming years in the family. Moreover, for patients who are non-responsive to chemotherapy, gene detection can help in identifying presence of mutations in cancer cells that are therapy resistant. Using this information, cancer treating facilities can provide apt therapies to kill tumor cells. In addition, growing technological advances have further influenced adoption of gene detection in testing cancer. In December 2020, Roche introduced Cobas PIK3CA, a mutation test that can detect PIK3CA mutations in people suffering from metastatic or advanced breast cancer. In this backdrop, demand for cancer testing is expected to drive the growth of the gene detection market.

Prevalence of Autoimmune Diseases to Call for Efficient Gene Detection Methods

Gradual increase in the occurrence of autoimmune diseases continues to fuel demand for gene detection. Using gene detection, patients and clinicians are able to identify and categorize various hereditary factors that can potentially result in occurrence of an autoimmune disease. Till date, scientists have identified eighty autoimmune diseases. According to NSCF (National Stem Cell Foundation), around 4% of the global population suffers from one or more of these 80, with most common ones being type 1 diabetes, rheumatoid arthritis, multiple sclerosis, scleroderma, Crohn’s disease, lupus and psoriasis. Being one of the causes of chronic illness, prevalence of autoimmune diseases continues to demand for efficient gene detection tests and services. Against this backdrop, companies are developing advanced methods for gene detection, such as sequencing and RT-PCR, which is expected to bolster growth of the gene detection market in the years to follow.

Rising COVID 19 Cases to Impact Gene Detection Market

COVID 19 pandemic has triggered an increase in production of genetic test kits. Increasing number of COVID cases has raised safety concerns among individuals in hospitals and other healthcare facilities, due to which healthcare facilities are including additional shifts to scale up COVID 19/ SARS CoV 2 tests. For instance, AvellinoCoV2, a rapid gene detection test facilitates diagnosing of COVID 19 by carrying out identification and isolation of genetic markers as approved by CDC and FDA. Concerns regarding rising COVID 19 cases continues to influence demand for advanced diagnostics and methods, in turn impacting the gene detection market.

North America to Remain at the Vanguard of Growth in Gene Detection Market

Growing demand for gene detection in analyzing ancestry related problems is expected to fuel market’s growth in North America. Moreover, high prevalence of autoimmune diseases in emerging economies is triggering adoption of advanced gene detection methods and kits. For instance, according to NIH (National Institute of Environmental Health Sciences), autoimmune diseases affect around 24 million individuals in the United States. Moreover, NIH reveals that autoimmune diseases affect 5%-8% of the population in the US, and the rate is expected to further increase. As per AARDA (American Autoimmune Related Diseases Association), cost associated with treatment of autoimmune diseases is around US$ 86 billion every year. This has propelled use of gene detection kits in an attempt to lower autoimmune incidences and expenditure. Also, growing product approvals by FDA coupled with presence of key players that are involved in research and innovation of novel gene detection methods is expected to drive the gene detection market in North America. For example, in 2020, FDA approved FoundationOne Liquid CDx, a gene detection test developed by Foundation Medicine Inc., which is based on liquid biopsy NGS.

Gene Detection Market Competitive Landscape

Key players in the gene detection market include Abbott Laboratories, Illumina Inc., Danaher, F Hoffmann-La Roche and BioRad Laboratories.

Regional Classification of the Global Gene Detection Market is Listed Below:

North America

U.S.
Canada

Europe

Germany
France
Spain
U.K.
Italy
Russia
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East and Africa

GCC
South Africa
Rest of Middle East & Africa

*Regions and countries are subject to change based on data availability.

Key Elements Included In The Study: Global Gene Detection Market

Gene Detection Market by Product/Technology/Grade, Application/End-user, and Region
Executive Summary (Opportunity Analysis and Key Trends)
Historical Market Size and Estimates, Value, 2018 - 2022
Market Value at Regional and Country Level, 2023 - 2030
Market Dynamics and Economic Overview
Market Size in Value, Growth Rates, and Forecast Figures, 2023 - 2030
Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies
Regional and Product/Grade/Application/End-user Price Trends Analysis
Value Chain and Five Force’s Analysis
Regional/Sub-region/Country Market Size and Trend Analysis
Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

The report will be prepared in a PPT format and will be delivered in a PDF format.

Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

1. Executive Summary
1.1. Global Gene Detection Market Outlook, 2018 - 2030 (US$ Million)
1.2. Global Gene Detection Market Incremental Opportunity, 2018 - 2030 (US$ Million)
1.3. Key Industry Trends

2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.1.1. Driver 1
2.2.1.2. Driver 2
  2.2.2. Restraints
2.2.2.1. Restraint 1
2.2.2.2. Restraint 2
  2.2.3. Market Opportunities Matrix
2.3. Porters Five Forces Analysis
2.4. Regulatory Guidelines
2.5. Covid-19 Impact Analysis

3. Global Gene Detection Market Outlook, 2018 - 2030
3.1. Global Gene Detection Market Outlook, by Technique, Value (US$ Mn), 2018 - 2030
  3.1.1. Key Highlights
3.1.1.1. Polymerase Chain Reaction
3.1.1.2. Microarray
3.1.1.3. Next Generation Sequencing
3.1.1.4. Other
  3.1.2. BPS Analysis/Market Attractiveness Analysis
3.2. Global Gene Detection Market Outlook, by Method, Value (US$ Mn), 2018 - 2030
  3.2.1. Key Highlights
3.2.1.1. Molecular
3.2.1.2. Biochemical
3.2.1.3. Chromosomal
  3.2.2. BPS Analysis/Market Attractiveness Analysis
3.3. Global Gene Detection Market Outlook, by Disease, Value (US$ Mn), 2018 - 2030
  3.3.1. Key Highlights
3.3.1.1. Genetic Disease
3.3.1.2. Cancer
3.3.1.3. Cardiovascular
3.3.1.4. Cognitive Dysfunction
3.3.1.5. Others
  3.3.2. BPS Analysis/Market Attractiveness Analysis
3.4. Global Gene Detection Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  3.4.1. Key Highlights
3.4.1.1. Hospitals & Clinics
3.4.1.2. Diagnostic Laboratories
3.4.1.3. Academic & Research Institutes
3.4.1.4. Others
  3.4.2. BPS Analysis/Market Attractiveness Analysis
3.5. Global Gene Detection Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
  3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Rest of the World
  3.5.2. BPS Analysis/Market Attractiveness Analysis

4. North America Gene Detection Market Outlook, 2018 - 2030
4.1. North America Gene Detection Market Outlook, by Technique, Value (US$ Mn), 2018 - 2030
  4.1.1. Key Highlights
4.1.1.1. Polymerase Chain Reaction
4.1.1.2. Microarray
4.1.1.3. Next Generation Sequencing
4.1.1.4. Others
  4.1.2. BPS Analysis/Market Attractiveness Analysis
4.2. North America Gene Detection Market Outlook, by Method, Value (US$ Mn), 2018 - 2030
  4.2.1. Key Highlights
4.2.1.1. Molecular
4.2.1.2. Biochemical
4.2.1.3. Chromosomal
  4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Gene Detection Market Outlook, by Disease, Value (US$ Mn), 2018 - 2030
  4.3.1. Key Highlights
4.3.1.1. Genetic Disease
4.3.1.2. Cancer
4.3.1.3. Cardiovascular
4.3.1.4. Cognitive Dysfunction
4.3.1.5. Others
  4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Gene Detection Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  4.4.1. Key Highlights
4.4.1.1. Hospitals & Clinics
4.4.1.2. Diagnostic Laboratories
4.4.1.3. Academic & Research Institutes
4.4.1.4. Others
  4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Gene Detection Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  4.5.1. Key Highlights
4.5.1.1. U.S.
4.5.1.2. Canada
  4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Gene Detection Market Outlook, 2018 - 2030
5.1. Europe Gene Detection Market Outlook, by Technique, Value (US$ Mn), 2018 - 2030
  5.1.1. Key Highlights
5.1.1.1. Polymerase Chain Reaction
5.1.1.2. Microarray
5.1.1.3. Next Generation Sequencing
5.1.1.4. Others
  5.1.2. BPS Analysis/Market Attractiveness Analysis
5.2. Europe Gene Detection Market Outlook, by Method, Value (US$ Mn), 2018 - 2030
  5.2.1. Key Highlights
5.2.1.1. Molecular
5.2.1.2. Biochemical
5.2.1.3. Chromosomal
  5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Gene Detection Market Outlook, by Disease, Value (US$ Mn), 2018 - 2030
  5.3.1. Key Highlights
5.3.1.1. Genetic Disease
5.3.1.2. Cancer
5.3.1.3. Cardiovascular
5.3.1.4. Cognitive Dysfunction
5.3.1.5. Others
  5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Gene Detection Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  5.4.1. Key Highlights
5.4.1.1. Hospitals & Clinics
5.4.1.2. Diagnostic Laboratories
5.4.1.3. Academic & Research Institutes
5.4.1.4. Others
  5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Gene Detection Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  5.5.1. Key Highlights
5.5.1.1. Germany
5.5.1.2. France
5.5.1.3. U.K.
5.5.1.4. Italy
5.5.1.5. Spain
5.5.1.6. Rest of Europe
  5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Gene Detection Market Outlook, 2018 - 2030
6.1. Asia Pacific Gene Detection Market Outlook, by Technique, Value (US$ Mn), 2018 - 2030
  6.1.1. Key Highlights
6.1.1.1. Polymerase Chain Reaction
6.1.1.2. Microarray
6.1.1.3. Next Generation Sequencing
6.1.1.4. Others
  6.1.2. BPS Analysis/Market Attractiveness Analysis
6.2. Asia Pacific Gene Detection Market Outlook, by Method, Value (US$ Mn), 2018 - 2030
  6.2.1. Key Highlights
6.2.1.1. Molecular
6.2.1.2. Biochemical
6.2.1.3. Chromosomal
  6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Gene Detection Market Outlook, by Disease, Value (US$ Mn), 2018 - 2030
  6.3.1. Key Highlights
6.3.1.1. Genetic Disease
6.3.1.2. Cancer
6.3.1.3. Cardiovascular
6.3.1.4. Cognitive Dysfunction
6.3.1.5. Others
  6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Gene Detection Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  6.4.1. Key Highlights
6.4.1.1. Hospitals & Clinics
6.4.1.2. Diagnostic Laboratories
6.4.1.3. Academic & Research Institutes
6.4.1.4. Others
  6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Gene Detection Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  6.5.1. Key Highlights
6.5.1.1. China
6.5.1.2. Japan
6.5.1.3. India
6.5.1.4. South Korea
6.5.1.5. Australia & New Zealand
6.5.1.6. Rest of Asia Pacific
  6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Rest of the World Gene Detection Market Outlook, 2018 - 2030
7.1. Rest of the World Gene Detection Market Outlook, by Technique, Value (US$ Mn), 2018 - 2030
  7.1.1. Key Highlights
7.1.1.1. Polymerase Chain Reaction
7.1.1.2. Microarray
7.1.1.3. Next Generation Sequencing
7.1.1.4. Others
  7.1.2. BPS Analysis/Market Attractiveness Analysis
7.2. Rest of the World Gene Detection Market Outlook, by Method, Value (US$ Mn), 2018 - 2030
  7.2.1. Key Highlights
7.2.1.1. Molecular
7.2.1.2. Biochemical
7.2.1.3. Chromosomal
  7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Rest of the World Gene Detection Market Outlook, by Disease, Value (US$ Mn), 2018 - 2030
  7.3.1. Key Highlights
7.3.1.1. Genetic Disease
7.3.1.2. Cancer
7.3.1.3. Cardiovascular
7.3.1.4. Cognitive Dysfunction
7.3.1.5. Others
  7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Rest of the World Gene Detection Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  7.4.1. Key Highlights
7.4.1.1. Hospitals & Clinics
7.4.1.2. Diagnostic Laboratories
7.4.1.3. Academic & Research Institutes
7.4.1.4. Others
  7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Rest of the World Gene Detection Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  7.5.1. Key Highlights
7.5.1.1. Latin America
7.5.1.2. Middle East & Africa
  7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Competitive Landscape
8.1. Company Market Share Analysis
8.2. Company Profiles
  8.2.1. Abbott Laboratories
8.2.1.1. Company Overview
8.2.1.2. Financial Overview
8.2.1.3. Technique Portfolio
8.2.1.4. Recent Developments
*Above details will include, but not be limited to below list of companies based on availability
  8.2.2. Progenity, Inc.
  8.2.3. Thermo Fischer Scientific
  8.2.4. Invitae Corporation
  8.2.5. Ambry Genetics
  8.2.6. Biocartis Group NV
  8.2.7. Eurofins Genomics LLC
  8.2.8. Myriad Genetics, Inc.
  8.2.9. Siemens Healthineers
  8.2.10. Others

9. Appendix
9.1. Research Methodology
9.2. Report Assumptions
9.3. Acronyms and Abbreviations

Gene Detection Market

Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Request Table of Contents / Information

Latest Reports

Our Research Methodology